Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy

Podobne zapisy

• Clinical Features of the Dilated Phase of Hypertrophic Cardiomyopathy in Comparison With Those of Dilated Cardiomyopathy
  od: Hamada, Tomoyuki, i wsp.
  Wydane: (2010)
• Serum Cardiac Troponin I is Related to Increased Left Ventricular Wall Thickness, Left Ventricular Dysfunction, and Male Gender in Hypertrophic Cardiomyopathy
  od: Kubo, Toru, i wsp.
  Wydane: (2009)
• Giant Left Atrial Myxoma in a Nonagenarian
  od: Matsumura, Yoshihisa, i wsp.
  Wydane: (2013)
• The appropriate dose of angiotensin‐converting‐enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?
  od: Ishida, Junichi, i wsp.
  Wydane: (2015)
• A Novel Disease Entity in Search of Its Own Identity　― Takotsubo Syndrome. Is It Really “Cardiomyopathy”? ―
  od: Doi, Yoshinori L., i wsp.
  Wydane: (2020)